Search

Embecta Corp

Fermé

SecteurSoins de santé

4.42 26.65

Résumé

Variation du prix de l'action

24h

Actuel

Min

3.51

Max

4.68

Chiffres clés

By Trading Economics

Revenu

-48M

-4.1M

Ventes

-39M

222M

P/E

Moyenne du Secteur

1.928

68.51

BPA

0.27

Rendement du dividende

16.48

Marge bénéficiaire

-1.849

Employés

1,850

EBITDA

-51M

45M

Recommandations

By TipRanks

Recommandations

Vente

Prévisions sur 12 Mois

-14.29% downside

Dividendes

By Acuity

Rendement du dividende

Moyenne du Secteur

16.48%

2.29%

Prochains Résultats

7 août 2026

Date du Prochain Dividende

15 sept. 2026

Date du Prochain Détachement de Dividende

27 août 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-327M

221M

Ouverture précédente

-22.23

Clôture précédente

4.42

Sentiment de l'Actualité

By Acuity

72%

28%

308 / 340 Classement par Healthcare

Embecta Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

6 août 2026, 23:42 UTC

Embecta Corp shares are higher in after-market hours, recovering from earlier lows. No specific news was identified to explain this movement.

5 août 2026, 22:36 UTC

News

Embecta Corp faces a securities fraud class action lawsuit over misleading fiscal statements, contributing to a modest decline in after-market trading.

4 août 2026, 19:26 UTC

Embecta Corp shares are higher during Tuesday's session, reaching a session high. No specific company news was identified to explain the upward movement.

3 août 2026, 20:03 UTC

Embecta Corp shares are higher today, benefiting from positive investor sentiment in the health care supplies sector amid a rising broader market.

31 juil. 2026, 21:02 UTC

Embecta Corp shares are lower in after-market hours, continuing a recent decline amid broader market concerns over inflation and rising interest rates.

30 juil. 2026, 21:02 UTC

Embecta Corp shares are higher in after-market trading, amid positive market sentiment focused on corporate earnings despite geopolitical tensions and inflation concerns.

29 juil. 2026, 19:04 UTC

Embecta Corp gains amid a strong Health Care Supplies sub-sector, despite pulling back from earlier session highs. Overall, shares are higher since Tuesday's close.

28 juil. 2026, 22:01 UTC

Embecta Corp shares are higher in after-market hours, continuing a positive trend since Tuesday's close. No specific news was identified to explain the movement.

27 juil. 2026, 18:03 UTC

Embecta Corp shares are trading higher, continuing a rise since Friday amid broader market movements and easing inflation concerns, despite earlier pulling back from session highs.

24 juil. 2026, 21:31 UTC

News

Embecta Corp is facing a securities class action lawsuit for allegedly misleading investors about its fiscal results, contributing to lower after-market hours trading.

22 juil. 2026, 18:02 UTC

News

Embecta Corp shares are lower today amid a securities fraud class action lawsuit filed by Levi & Korsinsky, LLP, targeting misrepresentation of financial health.

21 juil. 2026, 23:01 UTC

Embecta Corp shares are higher in after-market trading, reflecting a strong position above its 20-day moving average and near the upper end of its one-month range.

20 juil. 2026, 19:52 UTC

Embecta Corp shares are rising sharply, reaching the upper end of their one-month range amid positive broader market sentiment, particularly from Asian markets.

Comparaison

Variation de prix

Embecta Corp prévision

Objectif de Prix

By TipRanks

-14.29% baisse

Prévisions sur 12 Mois

Moyen 3 USD  -14.29%

Haut 3 USD

Bas 3 USD

Basé sur 2 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Vente

2 ratings

0

Achat

1

Maintien

1

Vente

Sentiment

By Acuity

308 / 340Classement par Soins de santé

Sentiment de l'Actualité

Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Embecta Corp

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
help-icon Live chat